RNVSNovartis AG Tokenized Stock (Reality)

The drug pipeline is concentrated in medical areas such as cardiovascular, immunology, neuroscience, and solid tumors. The company operates molecular screening laboratories and biological manufacturing facilities, advancing the clinical safety and efficacy testing of drug candidates. Approved medications are primarily sold in bulk to hospitals, specialty clinics, and government medical procurement departments across multiple countries.

• Macro context: RNVS is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.

Data as of Nov 1, 2026